RxDoctor Payments Data

Jeffery Dockery, MD

Family Medicine · Douglas, GANPI 1831182674

Payments from drug & device makers

$1,689in general payments, 2019–2025

Across 93 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$701
  • Johnson & Johnson$310
  • Merck$204
  • Gilead$179
  • AstraZeneca$110
  • EMD Serono, Inc.$69
  • plus $116 from 2 others

What the payments were for

  • Food & beverage$1,66198%
  • Education$282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company43$701
Johnson & Johnson(2 entities)18$310
Merck13$204
Gilead11$179
AstraZeneca1$110
EMD Serono, Inc.3$69
Amgen1$62
Theratechnologies Inc.3$54

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,689 in reported general payments places this provider in the 65th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$34,590
Medicare patients
172
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala219$868,739
GenvoyaElviteg/Cob/Emtri/Tenof Alafen67$280,614
TivicayDolutegravir Sodium104$242,859
DovatoDolutegravir Sodium/Lamivudine62$179,971
DescovyEmtricitabine/Tenofov Alafenam64$145,370
JulucaDolutegravir/Rilpivirine40$143,538
TriumeqAbacavir/Dolutegravir/Lamivudi31$103,631
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf16$75,507
OdefseyEmtricitab/Rilpiviri/Tenof Ala20$72,841
StribildElviteg/Cob/Emtri/Tenofo Disop17$59,265
IsentressRaltegravir Potassium25$48,695
Darunavir32$44,436
PifeltroDoravirine19$35,619
CompleraEmtricita/Rilpivirine/Tenof Df11$27,417
FarxigaDapagliflozin Propanediol20$11,699

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya, Descovy, Stribild$179$1,353,987367 claims
Viiv Healthcare CompanyTivicay, Dovato, Juluca, Triumeq$701$669,999237 claims
MerckIsentress, Pifeltro$204$84,31444 claims
Johnson & JohnsonComplera$310$27,41711 claims
AstraZenecaFarxiga$110$11,69920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Douglas

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →